Orchid3 Study CB38120 PHX
Orchid3 Study CB38120 PHX
We are recruiting at our Phoenix location for our 'Orchid3' clinical study that pays up to $11,000 for study related time and procedures.
CB38120 Requirements Include:• Ages: 18-55
About the Clinical Study
• Stipend: $11,000
• Length: One - 20 Night Stay
• This investigational drug is being developed for patients with Alpha-1 Antitrypsin Deficiency (AATD).
Study Schedule - Subject to Change
Group XXX
• Study Start: XXX
Learn more
Fill out the form to receive a phone call within 24 hours from a Celerion Study Participant Representative.
Want to talk to a rep?
Want to learn more about Clinical Trials:
• Stipend: $11,000
• Length: One - 20 Night Stay
• This investigational drug is being developed for patients with Alpha-1 Antitrypsin Deficiency (AATD).
Study Schedule - Subject to Change
Group XXX
• Study Start: XXX
• Screening Dates through XXX
Learn more
Fill out the form to receive a phone call within 24 hours from a Celerion Study Participant Representative.
Want to talk to a rep?
Study Participant Representatives at our Customer-Care-Center are available to answer questions.
1-866-445-7033
(United States Toll Free)
1-866-445-7033
(United States Toll Free)
Want to learn more about Clinical Trials:
From the Food and Drug Administration (FDA)
Why Healthy Subjects - Explainer Video
Celerion - Help Research - COVID Safety
Why Healthy Subjects - Explainer Video
Celerion - Help Research - COVID Safety